• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米氮平联合利培酮对 MK-801 诱导的小鼠物体识别试验改变的影响。

Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice.

机构信息

Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland.

出版信息

Pharmacol Rep. 2013;65(5):1401-6. doi: 10.1016/s1734-1140(13)71499-3.

DOI:10.1016/s1734-1140(13)71499-3
PMID:24399737
Abstract

BACKGROUND

Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve treatment of the negative and certain cognitive symptoms of schizophrenia.

METHODS

The aim of the present study was to evaluate the effect of mirtazapine and risperidone, given separately or jointly, on the impact of MK-801(an NMDA receptor antagonist), given prior to the first introductory session, on the object recognition memory in mice. To this end, we used the object recognition test in which animals were tested for the ability to discriminate between an old, familiar and a novel object. Mirtazapine (2.5 or 5 mg/kg) and risperidone (0.01 mg/kg) were given 30 min before MK-801, and MK-801 (0.1 or 0.2 mg/kg) was administered 30 min before the first introductory session. Memory retention was evaluated 1.5 h after the introductory session.

RESULTS

The obtained results showed that MK-801 (0.2 mg/kg) decreased memory retention when given before the introductory session. Co-treatment with risperidone (0.01 mg/kg) and mirtazapine (2.5 or 5 mg/kg) abolished the effect of MK-801, whereas those drugs given separately did not change the action of MK-801.

CONCLUSIONS

The obtained results suggest that mirtazapine may enhance the antipsychotic-like effect of risperidone in the animal test modeling some cognitive symptoms of schizophrenia. Further studies are necessary to elucidate its mechanism of action.

摘要

背景

一些临床报告表明,米氮平增强利培酮的活性可能有效地改善精神分裂症的阴性和某些认知症状的治疗效果。

方法

本研究的目的是评估米氮平与利培酮分别或联合给药,对先前首次介绍性治疗前给予的 MK-801(一种 NMDA 受体拮抗剂)对小鼠物体识别记忆的影响。为此,我们使用物体识别测试,其中动物被测试其区分旧的、熟悉的和新的物体的能力。米氮平(2.5 或 5mg/kg)和利培酮(0.01mg/kg)在给予 MK-801 前 30 分钟给予,MK-801(0.1 或 0.2mg/kg)在首次介绍性治疗前 30 分钟给予。介绍性治疗后 1.5 小时评估记忆保留。

结果

结果表明,MK-801(0.2mg/kg)在给予介绍性治疗前降低了记忆保留。与利培酮(0.01mg/kg)和米氮平(2.5 或 5mg/kg)联合治疗消除了 MK-801 的作用,而单独给予这些药物则没有改变 MK-801 的作用。

结论

研究结果表明,米氮平可能增强利培酮在模拟精神分裂症某些认知症状的动物试验中的抗精神病样作用。需要进一步研究以阐明其作用机制。

相似文献

1
Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice.米氮平联合利培酮对 MK-801 诱导的小鼠物体识别试验改变的影响。
Pharmacol Rep. 2013;65(5):1401-6. doi: 10.1016/s1734-1140(13)71499-3.
2
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.米氮平与利培酮联用对小鼠精神分裂症阳性症状动物模型的影响。
Pharmacol Rep. 2012;64(6):1567-72. doi: 10.1016/s1734-1140(12)70955-6.
3
The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice.艾司西酞普兰与利培酮联合治疗对MK-801诱导的小鼠物体识别试验变化的影响。
Pharmacol Rep. 2016 Feb;68(1):116-20. doi: 10.1016/j.pharep.2015.07.004. Epub 2015 Aug 1.
4
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.阿立哌唑联合抗抑郁药可逆转 MK-801 诱导的小鼠似精神分裂症症状。
Pharmacol Rep. 2018 Aug;70(4):623-630. doi: 10.1016/j.pharep.2018.02.022. Epub 2018 Feb 24.
5
The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats.利培酮与抗抑郁药联合治疗对MK - 801诱导的大鼠社会互动测试缺陷的影响。
Pharmacol Rep. 2015 Dec;67(6):1183-7. doi: 10.1016/j.pharep.2015.04.006. Epub 2015 Apr 24.
6
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.氟西汀或米氮平与利培酮联用对强迫游泳试验大鼠主动行为和血浆皮质酮浓度的影响。
Pharmacol Rep. 2012;64(6):1391-9. doi: 10.1016/s1734-1140(12)70936-2.
7
Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice.N-甲基-D-天冬氨酸受体拮抗剂MK-801对小鼠物体识别记忆不同阶段的差异性影响。
Neuroscience. 2007 Oct 12;149(1):123-30. doi: 10.1016/j.neuroscience.2007.07.019. Epub 2007 Jul 20.
8
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.利培酮与新型抗抑郁药联合长期治疗对大鼠额叶皮质多巴胺和 5-羟色胺水平的影响。
Pharmacol Rep. 2018 Oct;70(5):1023-1031. doi: 10.1016/j.pharep.2018.04.009. Epub 2018 May 1.
9
The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.利培酮对米氮平引起的大鼠前额皮质细胞外单胺变化的影响。
Pharmacol Rep. 2014 Dec;66(6):984-90. doi: 10.1016/j.pharep.2014.06.009. Epub 2014 Jun 21.
10
The NMDA receptor antagonist MK-801 fails to impair long-term recognition memory in mice when the state-dependency of memory is controlled.当记忆的状态依存性得到控制时,NMDA 受体拮抗剂 MK-801 未能损害小鼠的长期识别记忆。
Neurobiol Learn Mem. 2019 May;161:57-62. doi: 10.1016/j.nlm.2019.03.006. Epub 2019 Mar 19.

引用本文的文献

1
MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of in the mouse prefrontal cortex.MK-801 暴露诱导小鼠前额叶皮层中 的翻译效率增加和 mRNA 乙酰化过度。
Epigenetics. 2024 Dec;19(1):2417158. doi: 10.1080/15592294.2024.2417158. Epub 2024 Oct 26.
2
Investigating the potential of mirtazapine to induce drug-seeking behavior in free-choice drinking mouse model.研究米氮平在自由选择饮水小鼠模型中诱导觅药行为的可能性。
Saudi Pharm J. 2022 Dec;30(12):1809-1815. doi: 10.1016/j.jsps.2022.10.010. Epub 2022 Nov 2.
3
Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice.
氟哌啶醇吸入对 MK-801 和盐酸美金刚诱导的小鼠运动的影响。
Libyan J Med. 2020 Dec;15(1):1808361. doi: 10.1080/19932820.2020.1808361.